American Century Companies’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
22,165
+302
+1% +$27.5K ﹤0.01% 2177
2026
Q1
$2.1M Sell
21,863
-122
-0.6% -$12.2K ﹤0.01% 2098
2025
Q4
$2.14M Buy
21,985
+596
+3% +$51.1K ﹤0.01% 2064
2025
Q3
$1.52M Buy
21,389
+1,698
+9% +$113K ﹤0.01% 2168
2025
Q2
$1.18M Buy
19,691
+1,407
+8% +$77.1K ﹤0.01% 2226
2025
Q1
$960K Buy
18,284
+2,213
+14% +$124K ﹤0.01% 2261
2024
Q4
$884K Buy
16,071
+3,078
+24% +$162K ﹤0.01% 2300
2024
Q3
$653K Buy
12,993
+2,588
+25% +$119K ﹤0.01% 2381
2024
Q2
$457K Buy
10,405
+1,850
+22% +$78.7K ﹤0.01% 2475
2024
Q1
$376K Buy
8,555
+2,849
+50% +$126K ﹤0.01% 2551
2023
Q4
$271K Buy
5,706
+455
+9% +$19.1K ﹤0.01% 2608
2023
Q3
$233K Buy
+5,251
New +$244K ﹤0.01% 2545

Other funds holding IRMD

American Century Companies's IRMD Position: Q2 2026 in Review

American Century Companies increased its iRadimed (IRMD) stake by 1.4% in Q2 2026, buying an estimated $27.5K and bringing the position to 22,165 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

American Century Companies first reported a position in IRMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.14M in Q4 2025. 203 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • American Century Companies held 22,165 shares of iRadimed worth $2.12M as of Q2 2026.
  • American Century Companies bought 302 iRadimed shares in Q2 2026, an estimated $27.5K.
  • iRadimed made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2177 holding.
  • American Century Companies first reported a position in iRadimed in Q3 2023 and has held it in 12 quarters since.
  • American Century Companies's iRadimed position peaked at $2.14M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.